SR
CME icon

Swiss Re’s CME Group CME Stock Holding History

Swiss Re’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.7K Hold
60
– – 0.11% 143
2025
Q4 		$16.4K Buy
+60
New +$16.3K ﹤0.01% 157

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Swiss Re's CME Position: Q1 2026 in Review

Swiss Re held its CME Group (CME) position steady in Q1 2026 at 60 shares worth $17.7K. The position accounts for 0.11% of the portfolio, ranked #143.

Swiss Re first reported a position in CME in Q4 2025 and has held it in 2 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Swiss Re held 60 shares of CME Group worth $17.7K as of Q1 2026.
  • Swiss Re left its CME Group share count unchanged in Q1 2026.
  • CME Group made up 0.11% of Swiss Re's portfolio in Q1 2026, its #143 holding.
  • Swiss Re first reported a position in CME Group in Q4 2025 and has held it in 2 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Swiss Re's 13F filing for Q1 2026, filed 12 May 2026.